What is the treatment for orthostatic hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Orthostatic Hypotension

The first-line treatment for orthostatic hypotension should include non-pharmacological measures, with midodrine as the primary pharmacological intervention for symptomatic cases that don't respond to conservative management. 1, 2

Definition and Diagnosis

  • Orthostatic hypotension is defined as a decrease in systolic blood pressure ≥20 mmHg or diastolic blood pressure ≥10 mmHg within 3 minutes of standing 3
  • Common symptoms include dizziness, lightheadedness, blurred vision, weakness, fatigue, and less commonly syncope, dyspnea, and neck/shoulder pain 4

Treatment Algorithm

Step 1: Non-pharmacological Interventions (First-line)

  • Increase fluid intake to 2-2.5L daily and moderate salt intake (unless contraindicated) 5
  • Physical countermeasures:
    • Rise slowly from lying or sitting positions
    • Avoid prolonged standing
    • Elevate head of bed during sleep (10-20 degrees)
    • Use compression garments/stockings for lower extremities
    • Perform isometric counterpressure exercises (leg crossing, muscle tensing)
    • Maintain moderate physical activity to improve vascular tone 1, 5
  • Identify and discontinue medications that exacerbate orthostatic hypotension:
    • Antihypertensives
    • Diuretics
    • Alpha-blockers
    • Vasodilators
    • Tricyclic antidepressants 5

Step 2: Pharmacological Interventions (For symptomatic cases not responding to non-pharmacological measures)

First-line Medications:

  • Midodrine (FDA-approved for symptomatic orthostatic hypotension)
    • Dosing: 10 mg up to 2-4 times daily (last dose not later than 6 PM)
    • Mechanism: Alpha-1 agonist that increases vascular tone
    • Efficacy: Increases standing systolic BP by 15-30 mmHg at 1 hour after a 10 mg dose
    • Caution: Monitor for supine hypertension (BP >200 mmHg systolic) 2, 1

Second-line Medications:

  • Fludrocortisone (9-α-fluorohydrocortisone)

    • Dosing: Initial dose 0.05-0.1 mg daily, titrate to 0.1-0.3 mg daily
    • Mechanism: Sodium retention, vessel wall constriction, reduced vessel distensibility
    • Can be used in combination with midodrine for severe cases
    • Caution: Monitor for supine hypertension, hypokalemia, congestive heart failure, peripheral edema 1
  • Droxidopa (FDA-approved for neurogenic orthostatic hypotension)

    • Consider when midodrine and fludrocortisone are ineffective 1, 5

Additional Pharmacological Options:

  • For patients with morning orthostatic hypotension: administer medications in the evening 5
  • For patients on antihypertensives: consider bedtime administration 5
  • For patients with supine hypertension: use shorter-acting drugs at bedtime:
    • Guanfacine or clonidine
    • Shorter-acting calcium blockers (e.g., isradipine)
    • Shorter-acting β-blockers (atenolol, metoprolol tartrate)
    • Alternative: enalapril if unable to tolerate preferred agents 1

Special Considerations

Treatment Goals

  • Focus on symptom improvement rather than blood pressure normalization 1
  • Improve standing time and ability to perform daily activities 2
  • Balance treatment of orthostatic hypotension with management of supine hypertension 6

Monitoring

  • Regular blood pressure measurements in supine and standing positions to assess treatment effectiveness 5
  • Monitor for supine hypertension, especially with pressor medications 5
  • Continue treatment only for patients who report significant symptomatic improvement 2

Pitfalls and Caveats

  • Avoid excessive supine hypertension when treating orthostatic hypotension 2
  • Be cautious with fludrocortisone in patients with heart failure or supine hypertension 6
  • Midodrine can cause marked elevation of supine blood pressure (>200 mmHg systolic) 2
  • Avoid the supine position in patients with supine hypertension, as this triggers pressure natriuresis and sodium loss 6
  • The use of any opioids for management of symptoms should be avoided due to addiction risk 1

By following this algorithm and considering both non-pharmacological and pharmacological interventions, most patients with orthostatic hypotension can achieve significant symptom improvement and better quality of life.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Orthostatic Hypotension: A Practical Approach.

American family physician, 2022

Research

Evaluation and management of orthostatic hypotension.

American family physician, 2011

Guideline

Management of Sertraline-Associated Hypotension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.